Background: There are few published epidemiological studies concerning dystonia. Its true prevalence has been difficult to establish. There is no data published in Latin America on this matter. Methods: In this study the prevalence of dystonias in the Department of Antioquia (Colombia) was estimated using a capture-recapture methodology with log-linear modeling, including cases in 3 centers for neurological referrals that cover the Department of Antioquia from 2007 to 2012. Results: The overall prevalence was 712 per 1,000,000 (95% CI 487-937). Of the total of 874 patients, 79% had primary dystonias, and 75.5% had focal dystonias. The delay in diagnosis was longer for primary dystonias, with a median of 1 year. Conclusion: We found a high prevalence of dystonias in Antioquia. The frequency of the different types of dystonias, as well as the demographic characteristics of our patients, is similar to data from other populations of the world.

Geyer HL, Bressman SB: The diagnosis of dystonia. Lancet Neurol 2006;5:780-790.
Lalli S, Albanese A: The diagnostic challenge of primary dystonia: evidence from misdiagnosis. Mov Disord 2010;25:1619-1626.
Defazio G: The epidemiology of primary dystonia: current evidence and perspectives. Eur J Neurol 2010;17(suppl 1):9-14.
Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T: The prevalence of primary dystonia: a systematic review and meta-analysis. Mov Disord 2012;27:1789-1796.
Li SC, Schoenberg BS, Wang CC, et al: A prevalence survey of Parkinson's disease and other movement disorders in the peoples's republic of China. Arch Neurol 1985;42:655-657.
Kandil MR, Tohamy SA, Fattah MA, Ahmed HN, Farwiez HM: Prevalence of chorea, dystonia and athetosis in Assiut, Egypt: a clinical and epidemiological study. Neuroepidemiology 1994;13:202-210.
Muller J, Kiechl S, Wenning GK, Seppi K, Willeit J, Gasperi A, et al: The prevalence of primary dystonia in the general community. Neurology 2002;59:941-943.
Das SK, Banerjee TK, Biswas A, Roy T, Raut DK, Chaudhuri A, et al: Community survey of primary dystonia in the city of Kolkata, India. Mov Disord 2007;22:2031-2036.
Tallawy HN, Farghaly WM, Rageh TA, et al: Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt. Neuropsychiatr Dis Treat 2013;9:767-771.
El Tallawy HN, Farghaly WM, Rageh TA, et al: Epidemiology of major neurological disorders project in Al Kharga district, New Valley, Egypt. Neuroepidemiology 2010;35:291-297.
Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group: A prevalence study of primary dystonia in eight European countries. J Neurol 2000;247:787-792.
Laska EM: The use of capture - recapture methods in public health. Bull World Health Organ 2002;80:845.
Martyn CN: Capture-recapture methods in surveys of diseases of the nervous system. J Neurol Neurosurg Psychiatry 1998;64:2-3.
Sánchez JL, Uribe CS, Franco AF, Jiménez ME, Arcos-Burgos OM, Palacio LG: [Prevalence of myasthenia gravis in Antioquia, Colombia]. Rev Neurol 2002;34:1010-1012.
Cristiano E, Patrucco L, Rojas JI, Cáceres F, Carrá a, Correale J, et al: Prevalence of multiple sclerosis in Buenos Aires, Argentina using the capture-recapture method. Eur J Neurol 2009;16:183-187.
International Working Group for Disease Monitoring and Forecasting: Capture-recapture and multiple-record systems estimation I: history and theoretical development. Am J Epidemiol 1995;142:1047-1058.
Chao A, Tsay PK, Lin SH, Shau WY, Chao DY: The applications of capture-recapture models to epidemiological data. Stat Med 2001;20:3123-3157.
Koch GG, Davis SM, Anderson RL: Methodological advances and plans for improving regulatory success for confirmatory studies. Stat Med 1998;17:1675-1690.
Bedoya G, García J, Montoya P, Rojas W, Amézquita ME, Soto I, López MC, Ospina-Duque J, Ruiz-Linares A: [Isonymy analysis between 2 populations in northwestern Colombia]. Biomedica 2006;26:538-545.
Sugawara M, Watanabe S, Toyoshima I: Prevalence of dystonia in Akita Prefecture in Northern Japan. Mov Disord 2006;21:1047-1049.
Bhidayasiri R, Kaewwilai L, Wannachai N, Brenden N, Truong DD, Devahastin R: Prevalence and diagnostic challenge of dystonia in Thailand: a service-based study in a tertiary university referral centre. Parkinsonism Relat Disord 2011;17(suppl 1):S9-S15.
Asgeirsson H, Jakobsson F, Hjaltason H, Jonsdottir H, Sveinbjornsdottir S: Prevalence study of primary dystonia in Iceland. Mov Disord 2006;21:293-298.
Zilber N, Korczyn AD, Kahana E, Fried K, Alter M: Inheritance of idiopathic torsion dystonia among Jews. J Med Genet 1984;21:13-20.
Papantonio AM, Beghi E, Fogli D, et al: Prevalence of primary focal or segmental dystonia in adults in the district of Foggia, southern Italy: a service-based study. Neuroepidemiology 2009;33:117-123.
Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ 3rd: Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988;3:188-194.
Nakashima K, Kusumi M, Inoue Y, Takahashi K: Prevalence of focal dystonias in the western area of Tottori Prefecture in Japan. Mov Disord 1995;10:440-443.
Duffey PO, Butler AG, Hawthorne MR, Barnes MP: The epidemiology of the primary dystonias in the north of England. Adv Neurol 1998;78:121-125.
Castelon Konkiewitz E, Trender-Gerhard I, Kamm C, Warner T, Ben-Shlomo Y, Gasser T, et al: Service-based survey of dystonia in Munich. Neuroepidemiology 2002;21:202-206.
Le KD, Nilsen B, Dietrichs E: Prevalence of primary focal and segmental dystonia in Oslo. Neurology 2003;61:1294-1296.
Matsumoto S, Nishimura M, Shibasaki H, Kaji R: Epidemiology of primary dystonias in Japan: comparison with western countries. Mov Disord 2003;18:1196-1198.
Pekmezović T, Ivanović N, Svetel M, et al: Prevalence of primary late-onset focal dystonia in the Belgrade population. Mov Disord 2003;18:1389-1392.
Fukuda H, Kusumi M, Nakashima K: Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: comparison with prevalence evaluated in 1993. Mov Disord 2006;21:1503-1506.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.